Avecho Biotechnology has announced a collaboration with the Lambert Initiative to conduct a proof-of-concept study into the efficacy of topically applied CBD in relieving symptoms of osteoarthritis.
The Phase IIa study in Victoria has been initiated in response to growing demand from patients who are unsatisfied with pain management options for osteoarthritis of the hand.
It will test Avecho’s proprietary TPM technology for the delivery of a topical CBD gel formulation to painful joints on around 20 patients over a four-week period.
Assessment will include pain scores, functional scores and grip strength using a dynamometer and smartphone app.
Professor Iain McGregor from Lambert said: “CBD has shown early promise as a treatment for osteoarthritis, so we are interested to see if a topical formulation delivered at the site of pain will provide relief.
“This is a first step — if we do see any signals of success, we can begin examining other topically applied cannabinoids too.”
Around 50% of all women and 25% of all men will experience osteoarthritis of the hand by the time they reach 85.